You need

{credits} Credits

to reach your goal.

The FDA approved bepirovirsen as the first antisense oligonucleotide for chronic hepatitis B virus infection, alongside existing antiviral therapy for eligible adults without cirrhosis.

WASHINGTON — Children were twice as likely to begin and complete the HPV vaccine series at clinics that began recommending it at ages 9 and 10 instead of ages 11 and 12, according to findings presented at IDWeek.

WASHINGTON — A new retrospective cohort study revealed that more than half of early childhood exposures to hepatitis B virus come from household members other than the birth mother.

WASHINGTON — Costs associated with antimicrobial resistance neared $1 trillion in 2021, according to data presented at IDWeek.

Now that I am in the middle of my career and approaching 51 years old, I feel like my body does not bounce back as well as it used to.

For ophthalmologists, occupational pain can start early.

Patients with autoimmune rheumatic disease who received an updated or booster COVID-19 vaccine demonstrated lower odds of COVID-related hospitalization vs. those who received the initial series only, according to data

A multicenter cohort analysis revealed that more than 1 in 10 healthcare workers in the United States endure moderate-to-severe long COVID symptoms that can linger for months.

Amid a surge in syphilis cases in Alaska, an opt-out screening program implemented in Alaskan correctional facilities helped to identify new cases that would have likely been missed, according to a recent MMWR report.

Prediction marketplaces are taking their first steps into the pharmaceutical field — a move that some experts say may threaten the integrity of clinical trials.

Reminder from

Healio CME

You're almost at

{percent}%

completed.

Keep it going!

Your deadline is here.